Tapadar, S.; Fathi, S.; Wu, B.; Sun, C.Q.; Raji, I.; Moore, S.G.; Arnold, R.S.; Gaul, D.A.; Petros, J.A.; Oyelere, A.K.
Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers 2020, 12, 3095.
https://doi.org/10.3390/cancers12113095
AMA Style
Tapadar S, Fathi S, Wu B, Sun CQ, Raji I, Moore SG, Arnold RS, Gaul DA, Petros JA, Oyelere AK.
Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers. 2020; 12(11):3095.
https://doi.org/10.3390/cancers12113095
Chicago/Turabian Style
Tapadar, Subhasish, Shaghayegh Fathi, Bocheng Wu, Carrie Q. Sun, Idris Raji, Samuel G. Moore, Rebecca S. Arnold, David A. Gaul, John A. Petros, and Adegboyega K. Oyelere.
2020. "Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents" Cancers 12, no. 11: 3095.
https://doi.org/10.3390/cancers12113095
APA Style
Tapadar, S., Fathi, S., Wu, B., Sun, C. Q., Raji, I., Moore, S. G., Arnold, R. S., Gaul, D. A., Petros, J. A., & Oyelere, A. K.
(2020). Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers, 12(11), 3095.
https://doi.org/10.3390/cancers12113095